{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:53:16Z","timestamp":1791604396906,"version":"4.3.4"},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2026,10,9]]},"DOI":"10.1253\/circrep.cr-26-0135","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:11:19Z","timestamp":1789769479000},"page":"1685-1695","source":"Crossref","is-referenced-by-count":0,"title":["Limited Impact of High Bleeding Risk Calculation and Peri-Procedural Discussion on Dual-Antiplatelet Therapy Duration and Clinical Outcomes After Percutaneous Coronary Intervention"],"prefix":"10.1253","volume":"8","author":[{"given":"Tomoki","family":"Hattori","sequence":"first","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruka","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikito","family":"Takefuji","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ibayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Sobue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Nawano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Oishi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monami","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients. <i>JACC Cardiovasc Interv<\/i> 2013; 6: 1267\u20131274.","DOI":"10.1016\/j.jcin.2013.06.015"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Inohara T, Kohsaka S, Spertus JA, Masoudi FA, Rumsfeld JS, Kennedy KF, et al. Comparative trends in percutaneous coronary intervention in Japan and the United States, 2013 to 2017. <i>J Am Coll Cardiol<\/i> 2020; 76: 1328\u20131340.","DOI":"10.1016\/j.jacc.2020.07.037"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. G\u00e9n\u00e9reux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ, et al. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. <i>J Am Coll Cardiol<\/i> 2015; 66: 1036\u20131045.","DOI":"10.1016\/j.jacc.2015.06.1323"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). <i>Eur Heart J<\/i> 2018; 39: 213\u2013260.","DOI":"10.1093\/eurheartj\/ehx638"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Urban P, Meredith IT, Abizaid A, Pocock SJ, Carri\u00e9 D, Naber C, et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. <i>N Engl J Med<\/i> 2015; 373: 2038\u20132047.","DOI":"10.1056\/NEJMoa1503943"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Windecker S, Latib A, Kedhi E, Kirtane AJ, Kandzari DE, Mehran R, et al. Polymer-based or polymer-free stents in patients at high bleeding risk. <i>N Engl J Med<\/i> 2020; 382: 1208\u20131218.","DOI":"10.1056\/NEJMoa1910021"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Valgimigli M, Frigoli E, Heg D, Tijssen J, J\u00fcni P, Vranckx P, et al. Dual antiplatelet therapy after PCI in patients at high bleeding risk. <i>N Engl J Med<\/i> 2021; 385: 1643\u20131655.","DOI":"10.1056\/NEJMoa2108749"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: A Consensus Document from the Academic Research Consortium for High Bleeding Risk. <i>Eur Heart J<\/i> 2019; 40: 2632\u20132653.","DOI":"10.1093\/eurheartj\/ehz372"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 Guideline Focused Update on antithrombotic therapy in patients with coronary artery disease. <i>Circ J<\/i> 2020; 84: 831\u2013865.","DOI":"10.1253\/circj.CJ-19-1109"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, et al. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores. <i>J Am Heart Assoc<\/i> 2018; 7: e008708.","DOI":"10.1161\/JAHA.118.008708"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamamoto K, Natsuaki M, Yoshikawa Y, Morimoto T, Shiomi H, Watanabe H, et al. Effects of body weight on bleeding and ischemic events in patients undergoing percutaneous coronary intervention: From the CREDO-Kyoto Registry Cohort-2. <i>Circ J<\/i> 2020; 84: 1734\u20131745.","DOI":"10.1253\/circj.CJ-20-0343"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). <i>Circulation<\/i> 2018; 138: e618\u2013e651.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Nakamura S, et al. Dual antiplatelet therapy duration after multivessel optimal intravascular ultrasound-guided percutaneous coronary intervention. <i>Circ J<\/i> 2023; 87: 1661\u20131671.","DOI":"10.1253\/circj.CJ-23-0141"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yamamoto K, Watanabe H, Morimoto T, Obayashi Y, Natsuaki M, Domei T, et al. Clopidogrel monotherapy after 1-month DAPT in patients with high bleeding risk or complex PCI. <i>JACC Asia<\/i> 2023; 3: 31\u201346.","DOI":"10.1016\/j.jacasi.2022.09.011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ishida M, Shimada R, Takahashi F, Niiyama M, Ishisone T, Matsumoto Y, et al. One-month dual antiplatelet therapy followed by P2Y<sub>12<\/sub> inhibitor monotherapy after biodegradable polymer drug-eluting stent implantation: The REIWA region-wide registry. <i>Circ J<\/i> 2024; 88: 876\u2013884.","DOI":"10.1253\/circj.CJ-24-0091"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kang J, Abdul Ghapar AK, Selvaraj K, Hur SH, Tam CC, Jang Y, et al. One-month dual antiplatelet therapy in high bleeding risk Asian patients undergoing percutaneous coronary intervention: Onyx ONE Clear 2-year results. <i>Circ Rep<\/i> 2024; 6: 333\u2013340.","DOI":"10.1253\/circrep.CR-24-0037"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Correa MF, Li Y, Kum HC, Lawley MA. Assessing the effect of clinical inertia on diabetes outcomes: A modeling approach. <i>J Gen Intern Med<\/i> 2019; 34: 372\u2013378.","DOI":"10.1007\/s11606-018-4773-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Natsuaki M, Kimura T. Antiplatelet therapy after percutaneous coronary intervention: Past, current and future perspectives. <i>Circ J<\/i> 2022; 86: 741\u2013747.","DOI":"10.1253\/circj.CJ-21-0751"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused Update of the ACC\/AHA\/SCAI 2005 Guideline Update for percutaneous coronary intervention: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. <i>Circulation<\/i> 2008; 117: 261\u2013295.","DOI":"10.1161\/CIRCULATIONAHA.107.188208"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Natsuaki M, Morimoto T, Shiomi H, Ehara N, Taniguchi R, Tamura T, et al. Application of the modified high bleeding risk criteria for Japanese patients in an all-comers registry of percutaneous coronary intervention: From the CREDO-Kyoto Registry Cohort-3. <i>Circ J<\/i> 2021; 85: 769\u2013781.","DOI":"10.1253\/circj.CJ-20-0836"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ansari M, Shlipak MG, Heidenreich PA, Van Ostaeyen D, Pohl EC, Browner WS, et al. Improving guideline adherence: A randomized trial evaluating strategies to increase beta-blocker use in heart failure. <i>Circulation<\/i> 2003; 107: 2799\u20132804.","DOI":"10.1161\/01.CIR.0000070952.08969.5B"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ghazi L, Yamamoto Y, Riello RJ, Coronel-Moreno C, Martin M, O\u2019Connor KD, et al. Electronic alerts to improve heart failure therapy in outpatient practice: A cluster randomized trial. <i>J Am Coll Cardiol<\/i> 2022; 79: 2203\u20132213.","DOI":"10.1016\/j.jacc.2022.03.338"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Drescher FS, Chandrika S, Weir ID, Weintraub JT, Berman L, Lee R, et al. Effectiveness and acceptability of a computerized decision support system using modified Wells criteria for evaluation of suspected pulmonary embolism. <i>Ann Emerg Med<\/i> 2011; 57: 613\u2013621.","DOI":"10.1016\/j.annemergmed.2010.09.018"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lee PT, Huang MH, Huang TC, Sung PS, Hsu CH, Huang YL, et al. Improvement of oral anticoagulant prescription and long-term clinical outcomes of patients with atrial fibrillation after implementation of a clinical decision support system in outpatient practice. <i>J Am Heart Assoc<\/i> 2025; 14: e038640.","DOI":"10.1161\/JAHA.124.038640"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: The STOPDAPT-2 randomized clinical trial. <i>JAMA<\/i> 2019; 321: 2414\u20132427.","DOI":"10.1001\/jama.2019.8145"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/10\/8_CR-26-0135\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:30:17Z","timestamp":1791603017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/10\/8_CR-26-0135\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-26-0135","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"CR-26-0135"}}